Condition: Immune-Mediated Hepatitis · Liver Failure · Hepatocellular Carcinoma · Sponsor: Third Affiliated Hospital, Sun Yat-Sen University
This study aims to investigate the efficacy and safety of artificial liver support system treatment for immune checkpoint inhibitors related liver failure in patients with hepatocellular carcinoma.
This description comes directly from the study's public registry record.
Wenxiong Xu, Doctor · +8613760783281 · xuwenx@mail.sysu.edu.cn
Liang Peng, Doctor · +8613533978874 · pliang@mail.sysu.edu.cn
Always discuss trial participation with your own doctor first.
| Third Affiliated Hospital of Sun Yat-sen University | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05484908